3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
5
Completed
2
Not yet recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Prostatic Neoplasms
1
Lupus Erythematosus, Systemic
1
Colorectal Neoplasms
1
Interventions
pembrolizumab
245
Nivolumab
141
Cisplatin
135
Cyclophosphamide
134
Paclitaxel
113
Carboplatin
108
Gemcitabine
98
Radiotherapy
83
Dexamethasone
83
Docetaxel
78
atezolizumab
68
Ipilimumab
68
Doxorubicin
62
Fluorouracil
60
Blood Specimen Collection
58
Bevacizumab
58
fludarabine
54
Rituximab
54
Etoposide
53
Oxaliplatin
52
Surveys and Questionnaires
49
Lenalidomide
49
Prednisone
48
Standard of Care
45
Magnetic Resonance Spectroscopy
45
Capecitabine
45
Radiosurgery
44
Cetuximab
44
lenvatinib
43
durvalumab
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
High-Intensity Interval Training
×
1 year
×
Clear all
NCT04558398
2026-04-29
ICCE-Mito
University of Nottingham
Phase NA
Completed
15 enrolled
NCT05478018
2025-09-09
LUPEX
Rigshospitalet, Denmark
Phase NA
Completed
55 enrolled